<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05617872</url>
  </required_header>
  <id_info>
    <org_study_id>K2379</org_study_id>
    <nct_id>NCT05617872</nct_id>
  </id_info>
  <brief_title>Vinegar-induced Collection of Duodenal Pancreatic Juice Via Endoscopic Ultrasound</brief_title>
  <official_title>Vinegar-induced Collection of Duodenal Pancreatic Juice Via Endoscopic Ultrasound</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking Union Medical College Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking Union Medical College Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this clinical trial is to learn about the feasibility of collecting pancreatic&#xD;
      juice through duodenal aspiration by ultrasound endoscopy (EUS) for molecular marker testing&#xD;
      after intraduodenal infusion of vinegar in patients with suspected pancreatic cancer and who&#xD;
      are scheduled to have endoscopic ultrasound with fine needle aspiration (EUS-FNA). The main&#xD;
      questions it aims to answer are:&#xD;
&#xD;
        -  Is vinegar-induced collection of duodenal pancreatic juice via endoscopic ultrasound&#xD;
           feasible?&#xD;
&#xD;
        -  What is the best operating condition (amount of vinegar, collection time, etc.) of&#xD;
           vinegar-induced collection of duodenal pancreatic juice via endoscopic ultrasound?&#xD;
&#xD;
      Participants will have EUS as scheduled, during which different amount of vinegar will be&#xD;
      infused into duodenum and then pancreatic juice be collected for different time via suction&#xD;
      by EUS.&#xD;
&#xD;
      Researchers will compare the amount of collected pancreatic juice and molecular marker level&#xD;
      in different groups to determine the best operating condition for vinegar-induced collection&#xD;
      of duodenal pancreatic juice via endoscopic ultrasound.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a single center, prospective, randomized-controlled study. Participants who are&#xD;
      diagnosed as suspected pancreatic cancer and are schedule to have EUS-FNA will have saline or&#xD;
      different amount of vinegar infused into duodenum and pancreatic juiced collected via EUS&#xD;
      suction during different period of time under intravenous anesthesia.&#xD;
&#xD;
      The collected pancreatic juice will be weighed instantly and frozen in 10 minutes under -80â„ƒ&#xD;
      for further tests.&#xD;
&#xD;
      Researchers will compare the weight, cfDNA (cell free DNA) concentration, PLA2G1B&#xD;
      (Phosphatidylcholine 2-acylhydrolase 1B) concentration, immunoglobulin concentration and KRAS&#xD;
      (Kirsten rat sarcoma viral oncogene) mutation load of collected pancreatic juice from&#xD;
      different arms.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2022</start_date>
  <completion_date type="Anticipated">November 2023</completion_date>
  <primary_completion_date type="Anticipated">October 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>cfDNA concentration</measure>
    <time_frame>The collected pancreatic juice will be tested in 6 months.</time_frame>
    <description>cfDNA concentration of collected pancreatic juice of patients in different arms</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>PLA2G1B concentration</measure>
    <time_frame>The collected pancreatic juice will be tested in 6 months.</time_frame>
    <description>PLA2G1B concentration of collected pancreatic juice of patients in different arms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Immunoglobulin (Ig) concentration</measure>
    <time_frame>The collected pancreatic juice will be tested in 6 months.</time_frame>
    <description>Immunoglobulin (Ig) concentration of collected pancreatic juice of patients in different arms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>KRAS mutation load</measure>
    <time_frame>The collected pancreatic juice will be tested in 6 months.</time_frame>
    <description>KRAS mutation load detected of collected pancreatic juice of patients in different arms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weight</measure>
    <time_frame>The pancreatic juice will be weighed instantly 1 day (once) collected by EUS</time_frame>
    <description>weight in grams of collected pancreatic juice of patients in different arms</description>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Pancreatic Cancer</condition>
  <arm_group>
    <arm_group_label>Saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>20ml saline infused into duodenum and suction for 5 minutes via EUS</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vinegar 20ml</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>20ml vinegar infused into duodenum and suction for 5 minutes via EUS</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vinegar 40ml</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>40ml vinegar infused into duodenum and suction for 5 minutes via EUS</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vinegar 20ml, 0-5min</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>20ml vinegar infused into duodenum and pancreatic juice collected via EUS suction during the first 5 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vinegar 20ml, 5-10min</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>20ml vinegar infused into duodenum and pancreatic juice collected via EUS suction during the 5-10 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vinegar 20ml, 10-15min</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>20ml vinegar infused into duodenum and pancreatic juice collected via EUS suction during the 10-15 minutes</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vinegar 20ml</intervention_name>
    <description>20ml vinegar infused into duodenum and suction for 5 minutes via EUS</description>
    <arm_group_label>Vinegar 20ml</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline</intervention_name>
    <description>20ml saline infused into duodenum and suction for 5 minutes via EUS</description>
    <arm_group_label>Saline</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vinegar 40ml</intervention_name>
    <description>40ml vinegar infused into duodenum and suction for 5 minutes via EUS</description>
    <arm_group_label>Vinegar 40ml</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vinegar 20ml, 3 phases</intervention_name>
    <description>20ml vinegar infused into duodenum and pancreatic juice collected via EUS suction during the first 5 minutes, 5-10 minutes, and 10-15 minutes, separately.</description>
    <arm_group_label>Vinegar 20ml, 0-5min</arm_group_label>
    <arm_group_label>Vinegar 20ml, 10-15min</arm_group_label>
    <arm_group_label>Vinegar 20ml, 5-10min</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age: 18 years old or older&#xD;
&#xD;
          -  Diagnosis: CT, MRI, transabdominal ultrasound or other imaging examinations showed a&#xD;
             pancreatic mass, and 3 endoscopists agreed on the diagnosis of suspected pancreatic&#xD;
             cancer&#xD;
&#xD;
          -  EUS-FNA is required to perform further treatment strategy&#xD;
&#xD;
          -  The patient can understand the study protocol, is willing to participate in the study&#xD;
             and can provide written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  The patient's clinical and imaging features do not support the diagnosis of suspected&#xD;
             pancreatic cancer, judged by 3 endoscopists&#xD;
&#xD;
          -  The patient refuses to have EUS-FNA&#xD;
&#xD;
          -  The patient is unsuitable for EUS-FNA because of his/her general condition, or&#xD;
             contraindicated for anesthesia&#xD;
&#xD;
          -  The patient's imaging suggests severe pancreatic duct obstruction&#xD;
&#xD;
          -  The patient cannot understand the conditions and objectives of this study, or refuse&#xD;
             to participate in the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xi Wu, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Peking Union Medical College Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Wen Shi, M.D.</last_name>
    <phone>+8613699256758</phone>
    <email>ysfn_2005@126.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Peking Union Medical College Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100730</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xi Wu, M.D.</last_name>
      <phone>+8613683296860</phone>
      <email>wxpumch@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2022</verification_date>
  <study_first_submitted>November 6, 2022</study_first_submitted>
  <study_first_submitted_qc>November 15, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 16, 2022</study_first_posted>
  <last_update_submitted>November 15, 2022</last_update_submitted>
  <last_update_submitted_qc>November 15, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">November 16, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Peking Union Medical College Hospital</investigator_affiliation>
    <investigator_full_name>Wu Xi</investigator_full_name>
    <investigator_title>Associated Professor, M.D.</investigator_title>
  </responsible_party>
  <keyword>pancreatic cancer</keyword>
  <keyword>Endoscopic ultrasound</keyword>
  <keyword>pancreatic juice</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatic Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetic Acid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

